The United States Army Medical Research Institute of Infectious Diseases completes in vitro studies for the antimicrobial activity of Cethromycin-HCl against bacterial biothreat pathogens.
The United States Army Medical Research Institute of Infectious Diseases evaluated the in vitro antimicrobial activity of cethromycin-HCL against bacterial biothreat pathogens Bacillus anthracis (BA), Francisella tularensis (FT), Yersinia pestis (YP), Burkholderia mallei (BM), and Burkholderia pseudomallei (BP).